Barco, Stefano
Russo, Mariaconcetta
Vicaut, Eric
Becattini, Cecilia
Bertoletti, Laurent
Beyer-Westendorf, Jan
Bouvaist, Hélène
Couturaud, Francis
Danays, Thierry
Dellas, Claudia
Duerschmied, Daniel
Empen, Klaus
Ferrari, Emile
Galiè, Nazzareno
Jiménez, David
Klok, Frederikus A.
Kostrubiec, Maciej
Kozak, Matija
Kupatt, Christian
Lang, Irene M.
Lankeit, Mareike
Meneveau, Nicolas
Palazzini, Massimiliano
Pruszczyk, Piotr
Rugolotto, Matteo
Salvi, Aldo
Sanchez, Olivier
Schellong, Sebastian
Sobkowicz, Bozena
Meyer, Guy
Konstantinides, Stavros V.
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (BMBF 01KG0802, 01EO1003 and 01EO1503, BMBF 01EO1003 and 01EO1503)
Programme Hospitalier de Recherche Clinique (PHRC AOM 03063, AOM 08231 and AOM 10171)
Article History
Received: 6 September 2018
Accepted: 10 December 2018
First Online: 18 December 2018
Compliance with ethical standards
:
: SB has received payment for travel accommodation/meeting expenses from Daiichi-Sankyo and Bayer HealthCare. MR has received congress and travel payments from NovoNordisk. DJ has served as an advisor or consultant for Bayer HealthCare Pharmaceuticals. FAK reports research grants from Bayer, Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi-Sankyo, MSD and Actelion. OS has received payment for travel accommodation/meeting expenses from Bayer HealthCare, MSD, Actelion, Boehringer Ingelheim, Chiesi; board membership, consultancy and lecture honoraria to his institution from Actelion, Bayer HealthCare, Pfizer—BMS, and Chiesi; and institutional grants from Bayer HealthCare, Actelion, Daiichi-Sankyo, MSD and Portola. SVK reports having received consultancy and lecture honoraria from Bayer HealthCare, Boehringer Ingelheim, Daiichi-Sankyo, and Pfizer—Bristol-Myers Squibb; payment for travel accommodation/ meeting expenses from Bayer HealthCare; and institutional grants from Boehringer Ingelheim, Bayer HealthCare, Daiichi Sankyo, and MSD. Other authors: none reported.